AI assistant
Climb Bio, Inc. — Director's Dealing 2021
Aug 10, 2021
33982_dirs_2021-08-09_7bceecae-24ee-46ed-950e-a49462f67396.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 3 — Initial Statement of Beneficial Ownership
Issuer: Eliem Therapeutics, Inc. (ELYM)
CIK: 0001768446
Period of Report: 2021-08-09
Reporting Person: RA CAPITAL MANAGEMENT, L.P. (Director, 10% Owner)
Reporting Person: RA Capital Healthcare Fund LP (Director, 10% Owner)
Reporting Person: RA Capital Nexus Fund, L.P. (Director, 10% Owner)
Reporting Person: RA Capital Nexus Fund II, L.P. (Director, 10% Owner)
Reporting Person: Kolchinsky Peter (Director, 10% Owner)
Reporting Person: Shah Rajeev M. (Director, 10% Owner)
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 2867219 | Indirect |
| Common Stock | 216113 | Indirect |
Holdings (Derivative)
| Security | Exercise Price | Expiration | Underlying | Shares | Ownership |
|---|---|---|---|---|---|
| Series A Preferred Stock | $ | Common Stock (2639507) | Indirect | ||
| Series A-1 Preferred Stock | $ | Common Stock (1415002) | Indirect | ||
| Series B Preferred Stock | $ | Common Stock (673076) | Indirect | ||
| Series A Preferred Stock | $ | Common Stock (708333) | Indirect | ||
| Series A-1 Preferred Stock | $ | Common Stock (518164) | Indirect | ||
| Series B Preferred Stock | $ | Common Stock (288461) | Indirect | ||
| Series A Preferred Stock | $ | Common Stock (485493) | Indirect | ||
| Series A-1 Preferred Stock | $ | Common Stock (139481) | Indirect |
Footnotes
F1: Each share of Series A Preferred Stock, Series A-1 Preferred Stock and Series B Preferred Stock (collectively, the "Preferred Stock") is convertible at the option of the holder and will automatically convert into one share of Common Stock of the Issuer upon the closing of the Issuer's initial public offering. The Preferred Stock has no expiration date.
F2: Shares held directly by RA Capital Healthcare Fund, L.P. (the "Fund").
F3: RA Capital Management, L.P. (the "Adviser") is the investment manager for the Fund, RA Capital Nexus Fund, L.P. (the "Nexus Fund"), RA Capital Nexus Fund II, L.P. (the "Nexus Fund II") and a separately managed account (the "Account"). The general partner of the Adviser is RA Capital Management GP, LLC (the "Adviser GP"), of which Dr. Peter Kolchinsky and Mr. Rajeev Shah are the managing members. The Adviser, the Adviser GP, Dr. Kolchinsky, and Mr. Shah disclaim beneficial ownership of any of the reported securities, except to the extent of their pecuniary interest therein.
F4: Shares held directly by the Nexus Fund.
F5: Shares held directly by the Nexus Fund II.
F6: Shares held directly by the Account.